Lawyers for litigation

Glass Hardware Australia Pty Ltd v TCT Group Pty Ltd [2024] FCAFC 95

Glass Hardware Australia Pty Ltd v TCT Group Pty Ltd [2024] FCAFC 95

PATENTS – innovation patent relating to hinges – infringement – validity – whether primary judge erred in the proper construction of the invention disclosed

PATENTS – validity – lack of clear and complete description – classical sufficiency – “relevant range” – s 40(2)(a) of the Patents Act 1990 (Cth) – whether primary judge erred in finding specifications did not enable skilled addressee to perform invention over the whole area claimed without undue burden

PATENTS – validity – lack of support – s 40(3) of the Act – comparison between invention specified in the claims and that described in the specification – technical contribution to the art


Related cases about Patents

  • Oxford Nanopore Technologies Plc v MGI Aust PL [2025] FCA 572

    PRACTICE AND PROCEUDRE – application to set aside notice to produce served on prospective applicant – where prospective respondent’s nanopore sequencing devices may fall within the scope of one or more claims of patents owned by the prospective applicant – where category 1 seeks documents recording or evidencing prospective applicant’s belief that it may have…

  • MSA 4X4 Accessories PL v Clearview Towing Mirrors PL (Discovery) [2025] FCA 375

    PATENTS – discovery – significant claim for damages following liability judgment – discovery application successful with modifications made to categories of discovery sought Related cases about Patent disputes Original article available at: https://www.judgments.fedcourt.gov.au/judgments/Judgments/fca/single/2025/2025fca0375For more information, see the original judgement.

  • Novartis AG v Pharmacor PL [2025] FCAFC 33

    PATENTS – infringement – standard patent for a pharmaceutical composition containing certain active pharmaceutical ingredients – claim construction – whether primary judge erred in construction of claim as not including a pharmaceutical composition where the active pharmaceutical ingredient is in the form of a complex in which the ions are associated by non-covalent bonds –…

Original article available at: https://www.judgments.fedcourt.gov.au/judgments/Judgments/fca/full/2024/2024fcafc0095

For more information, see the original judgement.

Send this to a friend